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Abstract
Background: The impact of radiofrequency current ablation (RFCA) on left ventricular (LV)
systolic and diastolic function in patients with atrioventricular nodal re-entrant tachycardia
(AVNRT) is not well established yet.
Methods: The study group consisted of 25 patients (18 W, mean age 43 ± 11) with recurrent
episodes of AVRT without any concomitant diseases. The control group was formed of
25 healthy volunteers. In both study and control groups, transthorasic echocardiography (TTE)
and Doppler were performed in order to assess LV systolic and diastolic function. In AVNRT
syndrome patients, TTE was followed by electrophysiology study and RFCA. TTE was re-
peated after six months in the study group.
Results: Significant differences were found between the study and control groups with regard
to LV systolic (FS — fractional shortening: 37 ± 4 vs. 42 ± 6%, p = 0.001; ESV — end-systolic
volume: 19 ± 4 vs. 17 ± 4 ml/m2, p = 0.03; EF — ejection fraction: 55 ± 5 vs. 62 ± 4%, p =
= 0.001) and diastolic function (E wave: 69 ± 17 vs. 84 ± 15 cm/s, p = 0.002; E/A: 1.09 ±
± 0.42 vs. 1.38 ± 0.27, p = 0.005; DT — duration difference between A and AR waves: 7 ± 29
vs. –28 ± ± 13 ms, p = 0.001; DT — deceleration time of E wave: 223 ± 34 vs. 177 ± 27 ms,
p = 0.001; IVRT — isovolumic relaxation time: 105 ± 15 vs. 86 ± 11 ms, p = 0.001; E/A
while Valsalva manoeuvre: 0.93 ± 0.35 vs. 1.25 ± 0.16, p = 0.001; AR — atrial reversal
velocity: 27 ± 7 vs. 14 ± ± 11 cm/s, p = 0.001) variables. In 6-month follow-up decrease in
LVESV (19 ± 4 vs. 17 ± ± 4 ml, p < 0.03) and increase in EF (55 ± 5 vs. 62 ± 4%, p < 0.001)
was noted. Doppler analysis showed an increase in E wave (69 ± 17 vs. 79 ± 20 cm/s, p < 0.02),
E/A ratio (1.09 ± ± 0.42 vs. 1.30 ± 0.27, p < 0.006) and decrease in A wave (68 ± 13 vs.
63 ± 10 cm/s, p < 0.02), DT (223 ± 34 vs. 179 ± 22 ms, p < 0.001), IVRT (105 ± 15 vs.
89 ± 11 ms, p < 0.001) and DT (7 ± 29 vs. –13 ± 28 ms, p < 0.001).
Conclusions: Successful RFCA of slow atrioventricular conduction pathway in patients with
AVNRT and AVRT results in improvement of LV systolic and diastolic function. (Cardiol J
2008; 15: 150–155)
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Introduction
Chronic supraventricular tachycardia may result
in dilated cardiomyopathy both in animals [1, 2] and
humans [3]. In addition, patients with frequent and
prolonged episodes of tachycardia are at risk of de-
veloping left ventricular (LV) dysfunction. Pharma-
cological control of heart rate or elimination of
tachycardia via current or surgical ablation may re-
verse LV dysfunction [4, 5]. We sought to determi-
ne whether radiofrequency current ablation (RFCA)
has an impact on LV systolic and diastolic function
in patients with atrioventricular node dissociation
and irregular episodes of atrioventricular nodal
re-entrant tachycardia (AVNRT).
Methods
From March 1998 to December 2000, 158 con-
secutive patients with symptomatic drug-resistant
tachycardia underwent an invasive electrophysio-
logy study (EPS) and RFCA of slow conduction pa-
thway within atrioventricular node. Having obtained
informed consent, transthoracic echocardiography
(TTE) followed by EPS and RFCA were performed.
Patients were included in the study group if, during
EPS presence, atrioventricular node dissociation
was confirmed and AVNRT was induced. Patients
with Wolf-Parkinson-White syndrome (n = 74), fa-
ilure to induce AVNRT during EPS (n = 5), conco-
mitant diseases such as coronary artery disease
(n = 2), valve disease (n = 17), chronic myocardi-
tis (n = 1), hypertension — defined as systolic blo-
od pressure exceeding 140 mm Hg and/or diastolic
blood pressure over 90 mm Hg during high blood
pressure or normal blood pressure on antihyperten-
sive drugs (n = 11), metabolic diseases (diabetes
mellitus: n = 1, hypothyroidism: n = 1), obesity
— defined as body mass index over 30 (n = 7), con-
duction disturbances (LBBB: n = 1), poor TTE
image (n = 8), and patients taking any drugs (n = 5)
were excluded from the study.
To define the frequency of AVRT episodes and
to reduce the error of precise AVNRT duration ba-
sed on patient history, the scale of AVRT occurrence
(Scale: 3 — at least once a week, 2 — at least once
a month, 1 — less than once a month) was introduced.
The study was approved by the local bioethi-
cal committee.
Transthoracic echocardiography
Transthorasic echocardiography (TTE) was
performed without any information on the patient
or clinical data, using an ACUSON 128XP with
a 2.5–3.5 MHz transducer. All measurements were
made according to established standards [6]. The
M-mode traces and Doppler signals were recorded
at 50 mm/s. The average of three consecutive cyc-
les was calculated for each parameter. Measure-
ments of LV end-diastolic (EDD), end-systolic
(ESD), left atrial (LAD), intraventricular septal
(IVS) and LV posterior wall (PW) end-diastolic and
end-systolic dimensions were made on M-mode
traces recorded from the parasternal long-axis view.
LV end-diastolic (EDV) and end-systolic volumes
(ESV) were acquired from the apical four-chamber
view. LV ejection fraction (EF) by bi-plane Simp-
son method, LV mass (M) and fractional shortening
(FS), IVS and PW thickening (IVSth, PWth) were
also calculated. Doppler parameters of mitral and
right upper pulmonary vein (RUPV) flow reflecting
LV filling were obtained from the apical four-cham-
ber view with a sample volume of 2–4 mm. Mitral
flow measurements included peak early transmitral
filling velocity during early diastole (E), peak trans-
mitral atrial filling velocity during late diastole (A),
deceleration time (DT — time elapsed between
peak E velocity and the point where the extrapola-
tion deceleration slope of the E velocity crosses the
zero baseline), isovolumic relaxation time (IVRT —
time between the aortic valve closure and mitral
valve opening) and duration of A wave (tA). Asses-
sment of RUPV flow involved systolic (S), diastolic
(D), atrial reversal (AR) peak velocities and duration
of AR (tAR) wave measurements. Ratio of E and A
(E/A) and S and D (S/D) waves and the difference
between the duration of AR and A waves (DT) were
calculated. Measurements of mitral and RUPV flows
allowed the assessment of LV diastolic function [7]:
1) normal, 2) slow isovolumic relaxation [IVRT
> 92 ms (< 30 years), IVRT > 100 ms (30–50
years), IVRT > 105 ms (> 50 years)], 3) slow ear-
ly LV filling [E/A < 1 and DT > 220 ms (< 50
years), E/A < 0.5 and DT > 280 (> 50 years), S/D
> 1.5 (< 50 years), S/D < 0.5 (> 50 years)], 4) mi-
tral flow pseudonormalization (E/A > 1, DT and
IVRT normal adjusted for age and complying with
at least three of the following criteria [8]: S < D,
E < A and increase in A velocity during Valsalva ma-
noeuvre, AR ≥ 0.35 m/s, DT = tAR-tA ≥ 20 ms), and
5) mitral flow restriction (E/A > 2, DT < 140 ms,
S/D < 0.5, AR > 0.35 m/s, DT > 30 ms).
Electrophysiology study
and ablation procedure
Electrophysiology study (EPS) and RFCA were
performed according to the previously described
procedure [9]. All antiarrhythmic drugs were
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discontinued at least three half-lives before the stu-
dy except from amiodarone which was withdrawn
two months before the study. EPS was performed
using quadripolar diagnostic electrodes introduced
under fluoroscopic guidance. Three of the electro-
des with a 0.5-cm interpolar distance were intro-
duced via femoral veins into the right atrial appen-
dage (HRA), His bundle area (HBE) and right ven-
tricle apex (RVA). A fourth quadripolar diagnostic
electrode recording uni- and bipolar signals from the
coronary sinus (CS) was introduced via the right
internal jugular vein. The electrode was positioned
in a standard location. The right atrium and right
ventricle were paced with impulses generated by
Biotronic (Quinton Electrophysiology Corp., Seat-
tle, WA, USA), recorded and displayed with the help
of a 1993 Quinton EPAmp electrophysiological mo-
nitoring system. Two stimulation protocols were
performed during the study: 1) programmed stimu-
lation of the HRA with 8 basic stimuli train and sub-
sequent single, and afterwards double extrastimuli
with gradually (20-ms step) shortened coupling in-
terval, and 2) incremental pacing protocol. Radio-
frequency catheter ablation was performed with the
ablation catheter placed at the site of earliest acti-
vation, using commercial ablation electrodes (Daig,
Cordis, Medtronic). Radiofrequency energy was
delivered at an energy of 40 W and temperature up
to 60°C, for 60 s. Stimulation protocols were repe-
ated after ablation RF in order to stimulate AVNRT
and to confirm elimination of tachyarrhythmia.
Statistical analysis
All values were expressed as mean ± SD. Dif-
ferences between study and control groups were
evaluated by Student’s unpaired test for continu-
ous variables and c2 analysis for discreet variables.
Analysis of systolic and diastolic function parame-
ters before and after RFCA was performed by Stu-
dent’s paired test for continuous variables. P value
< 0.05 was required to fulfil statistical significan-
ce. All calculations were performed using a com-
mercially available statistical package SAS 9.1.3
(SAS Institute Inc., Cary, NC).
Reproducibility
All measurements were made by two indepen-
dent observers and repeated in ten randomly cho-
sen patients at least one month from the baseline
TTE, in order to assess intra- and inter-observer
variability calculated as the difference of two valu-
es and their arithmetical mean quotient. Intra- and
inter-observer variability was found as follows: for
LV diameters: 1.7 ± 2.9% and 3.3 ± 2.1, LV volu-
mes: 3.5 ± 3.2% and 7.7 ± 2.8, FS: 2.3 ± 2.2% and
4.4 ± 2.6, EF: 4.5 ± 3.1 and 6.3 ± 3.4, mitral and
RUPV flow velocities: 2.6 ± 2.8 and 1.3 ± 2.5%,
DT and IVRT: 7.1 ± 5.4 and 9.1 ± 4.6%.
Results
In all patients, AVNRT (mean frequency 181 ±
± 16 beats/min, mean scale of occurrence 1.7 ± 0.5)
was induced during EPS. The study group charac-
teristics are presented in Table 1. No difference was
found between age, gender, body mass index, body
surface area and values of systolic and diastolic blo-
od pressure. Ablation RF successfully eliminated
tachyarrhythmia in 25 (100%) patients. There were
no major complications of the procedure. Minor
complications (inguinal bruising) occurred just in
one (4%) patient and no major complications. In
6-month follow-up, none of the patients experien-
ced recurrence of AVNRT episodes.
Systolic function
Results of LV systolic parameter comparison
between the study and control groups are presen-
ted in Table 2. Statistically significant differences
in LV fractional shortening, end-systolic volume and
ejection fraction were found between AVNRT and
control groups. Eleven (44%) patients presented
baseline LV ejection fraction below 55% (mean
51 ± 2%).
Table 1. Study sample.
Parameter AVNRT group (n = 25) Control group (n = 25) p
Age (years) 42.7 ± 11.3 42.0 ± 9.5 0.80
Gender 7 M (28%) 7 M (28%) 1.0
Body mass index [kg/m2] 24.1 ± 2.1 23.8 ± 2.2 0.67
Body surface area [m2] 1.8 ± 0.2 1.7 ± 0.1 0.31
Systolic blood pressure [mm Hg] 123.0 ± 11.1 123.4 ± 11.0 0.90
Diastolic blood pressure [mm Hg] 77.0 ± 7.9 78.2 ± 7.9 0.59
AVNRT — atrioventricular nodal re-entrant tachycardia
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Successful RFCA resulted in reduction of end-
systolic diameter and, in consequence, increase in
LV ejection fraction. LV systolic function parame-
ters, apart from LV fractional shortening, did not
differ between study and control groups post suc-
cessful RFCA.
Diastolic function
Comparison of LV diastolic function parame-
ters between study and control groups are shown
in Table 3. In five (20%) patients of the study gro-
up there were no LV diastolic function abnormali-
ties. However, slow isovolumic relaxation was
found in six (24%), slow early LV filling in nine (36%)
and mitral flow pseudonormalization in five (20%).
Restrictive filling patterns were not seen in any of
the AVNRT patients. Diastolic dysfunction was not
found in any subject from the control group.
Following successful RFCA in 22 (88%) pa-
tients, LV diastolic dysfunction was absent. Slow
isovolumic relaxation was found in two (8%) pa-
tients and slow early LV filling in one (4%). Mitral
flow pseudonormalization or restriction were not
present in any of the patients. In 18 (90%) patients
with baseline diastolic abnormalities, diastolic func-
tion improved post successful RFCA. In two (10%)
Table 2. Left ventricular systolic function characteristics of the study sample.
Variable Before RFCA (n = 25) Post RFCA Control group (n = 25) p* p** p***
Heart rate [1/min] 74 ± 9 72 ± 9 71 ± 7 0.22 0.42 0.77
EDD [mm/m2] 27 ± 2 27 ± 3 28 ± 3 0.08 0.91 0.11
ESD [mm/m2] 16 ± 4 16 ± 2 16 ± 2 0.98 0.80 0.76
LAD [mm/m2] 20 ± 25 19 ± 4 20 ± 23 0.64 0.88 0.59
FS (%) 37 ± 4 38 ± 6 42 ± 6 0.001 0.42 0.03
IVSth (%) 46 ± 16 47 ± 13 52 ± 18 0.19 0.80 0.23
PWth (%) 63 ± 18 62 ± 19 60.9 ± 15.4 0.88 0.78 0.88
EDV [ml/m2] 41 ± 7 41 ± 8 43.9 ± 12 0.52 0.81 0.41
ESV [ml/m2] 19 ± 4 15 ± 5 17 ± 4 0.03 0.004 0.37
EF (%) 55 ± 5 62 ± 5 62 ± 4 0.001 0.001 0.72
*p — comparison between AVNRT and control group; **p — comparison between AVNRT before and after radiofrequency current ablation (RFCA);
***p — comparison between AVNRT after RFCA and control group; EDD — LV end-diastolic diameter; ESD — LV end-systolic diameter; LAD — left
atrial end-diastolic diameter; M — LV mass; FS — LV fractional shortening; IVSth — intraventricular septal thickening; PWth — posterior wall thicke-
ning; EDV — LV end-diastolic volume; ESV — LV end-systolic volume; EF — LV ejection fraction
Table 3. Left ventricular diastolic function characteristics of the study sample.
Parameter Before RFCA (n = 65) Post RFCA Control group (n = 50) p* p** p***
E [cm/s] 69 ± 17 79 ± 20 84 ± 15 0.002 0.02 0.31
A [cm/s] 68 ± 13 63 ± 10 62 ± 11 0.11 0.02 0.86
E/A 1.09 ± 0.42 1.30 ± 0.27 1.38 ± 0.27 0.005 0.006 0.38
DT [ms] 7 ± 29 –13 ± 28 –28 ± 13 0.001 0.001 0.02
DT [ms] 223 ± 34 179 ± 22 177 ± 27 0.001 0.001 0.79
IVRT [ms] 105 ± 15 89 ± 11 86 ± 11 0.001 0.001 0.40
Ev [cm/s] 55 ± 16 61 ± 13 69 ± 12 0.001 0.08 0.03
Av [cm/s] 60 ± 13 58 ± 12 56 ± 11 0.20 0.17 0.52
E/Av 0.93 ± 0.35 1.09 ± 0.29 1.25 ± 0.16 0.001 0.04 0.03
S [cm/s] 55 ± 10 56 ± 11 58 ± 8 0.40 0.60 0.27
D [cm/s] 53 ± 13 51 ± 10 56 ± 8 0.27 0.71 0.06
S/D 1.09 ± 0.30 1.13 ± 0.28 1.07 ± 0.20 0.73 0.80 0.37
AR [cm/s] 27 ± 7 22 ± 8 14 ± 11 0.001 0.06 0.006
*p — comparison between AVNRT and control group; **p — comparison between AVNRT before and after radiofrequency current ablation (RFCA);
***p — comparison between AVNRT after RFCA and control group; E — peak early transmitral filling velocity during early diastole; A — peak transmi-
tral atrial filling velocity during late diastole; DT — duration difference between RUPV atrial reversal flow and mitral A wave; DT — deceleration time of
E wave; IVRT — isovolumic relaxation time; Ev — E wave during Valsalva manoeuvre; Av — A wave during Valsalva manoeuvre, S — systolic velocity
of right upper pulmonary vein (RUPV) flow; AR — atrial reversal velocity of RUPV flow
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patients after RFCA there was no regression of dia-
stolic dysfunction (one patient with slow isovolu-
mic relaxation, one patient with slow early LV fil-
ling). Successful RFCA resulted in an increase in
early mitral filling, early to atrial mitral flow ratio
at rest and during Valsalva manoeuvre and reduc-
tion of atrial mitral. Systolic and diastolic velocities
of RUPV flow did not change. The majority of LV
diastolic function parameters post successful RFCA
did not differ between study and control groups.
Although reduction of duration difference between
RUPV atrial reversal flow and mitral A wave and
increase in early transmitral filling velocity, early
to atrial transmitral flow ratio while Valsalva ma-
noeuvre increased post RFCA, they did not reach
the values observed in healthy subjects.
Discussion
Chronic supraventricular tachycardia may lead
to the development of congestive heart failure,
which has been well documented both in animal and
clinical models [1, 2, 10–12]. We have already shown
that recurrent episodes of re-entrant tachycardia
may also affect LV systolic and diastolic performan-
ce [13]. Several studies have reported improvement
of LV systolic function due to elimination of tachy-
cardia by ablation of atrioventricular conduction or
AP [14, 15]. However, regression of diastolic dys-
function as a result of tachycardia termination is not
clear. Tomita et al. demonstrated that in the 4-week
recovery period increase in LV diastolic and pulmo-
nary wedge pressure were still persistent [12].
Systolic function
Reversibility of LV dysfunction was observed by
Chen et al. in patients with frequent attacks of pro-
longed tachycardia and with incessant re-entrant ta-
chycardia post successful direct or radiofrequency
catheter ablation [16], by Cruz et al. [5] in patients
with permanent junctional reciprocating tachycardia
(PJRT) and by De Giovanni et al. [4] in children with
PJRT and ectopic atrial tachycardia treated by RFCA,
surgical or DC ablation. In our study elimination of
the arrhythmia was achieved by RFCA of slow ac-
cessory pathways within atrioventricular node. None
of the patients underwent surgical ablation, nor was
atrioventricular conduction block created in any sub-
ject. We observed improvement of LV fractional
shortening and ejection fraction post successful
RFCA as a result of reduction of LV end-systolic
without significant decrease in LV end-diastolic vo-
lume. Contrary to other studies [1, 2, 5, 11, 12, 16],
our patients did not have LV end-diastolic dilation.
This difference may be explained by the fact that not
only organic heart disease but also any concomitant
diseases or any drug intake were defined as exclu-
sion criteria from the study. Similar findings were
reported by Fishberger et al. [17] in patients with
ectopic atrial and permanent junctional reciprocating
tachycardia.
Diastolic function
We have already proven that recurrent episo-
des of AVNRT may result in LV diastolic dysfunc-
tion [13]. Studies reporting whether RFCA alter LV
diastolic performance are limited. Shyu et al. [18]
have shown that RFCA in patients with AVRT and
AVNRT affect left ventricular filling in short term
(48 h) observation. Reduction in early transmitral
filling velocity and E/A ratio were attributed to in-
crease in heart rate. However, parameters of trans-
mitral flow are not sufficient to assess LV diastolic
function, which was proved by Petrie et al. [19].
Eksik et al. [20] reported deterioration of LV dia-
stolic function due to RFCA in patients with vario-
us tachyarrhythmias (AVRT, AVNRT, right ventri-
cular outflow tract tachycardia). They analyzed not
only transmitral flow but also Tissue Doppler para-
meters. The most significant deterioration of LV
diastolic function was observed one hour and one
day after RFCA, and in one month’s time it partial-
ly improved. Those changes were explained by
thermal injury to myocardium, coagulation necro-
sis and, as a consequence, fibrosis. In neither of the
cited above studies re-entrant tachycardia itself was
taken into account as a potential factor of LV dia-
stolic function impairment. Induction of AVRT or
AVNRT is part of the EPS study.
Our study has demonstrated that successful
RFCA results in improvement of LV diastolic func-
tion in 6-month follow-up. Only in two (10%) pa-
tients with baseline diastolic abnormalities were
slow relaxation and slow early LV filling present
post RFCA. This may be explained by the age of
the patients (mean 53 ± 12) combined with scale
of AVNRT occurrence [2] and frequency of AVNRT
(185 ± 7 beats/min). Post RFCA, the majority of
transmitral flow parameters improved. Although
systolic and diastolic velocities of RUPV flow did
not alter significantly after RFCA, reduction in atrial
reversal flow was noted. It has to be taken into con-
sideration that there is no linear relation between
RUPV flow systolic and diastolic velocities and gra-
des of diastolic dysfunction. Therefore, mean valu-
es of those parameters may not differ before and
after ablation. The relation between those parame-
ters has been proved in other studies [21].
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Reduction of atrial reversal flow post RFCA was in-
significant and still different from values observed
in healthy subjects. Mele et al. [22] indicate that du-
ring AVRT in about 90% of cases atrial contraction
occurs against totally (AVNRT) or partially (AVRT)
closed atrioventricular valves. This results in re-
peated mean and peak atrial pressure elevations and
may lead to atrial remodelling which could be per-
sistent in long-term follow-up.
Clinical implications
Elimination of AVNRT in patients with atrio-
ventricular node dissociation results in improve-
ment of LV systolic and diastolic performance. The-
refore, given the results and the low rate of com-
plications of RFCA [23], such treatment should be
considered early in patients with atrioventricular
node dissociation and recurrent episodes of
AVNRT.
Study limitations
Echocardiographic findings were not verified
by invasive mean LA pressure or LVEDP measu-
rements which could bring an additional value to the
study. LV diastolic function evaluation was limited
to conventional Doppler but not Tissue Doppler or
propagation velocity imaging. However, to the best
of our knowledge this is the first study providing
information on LV diastolic performance in patients
with AVNRT undergoing successful RFCA.
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